CRIM1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.167200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.063400E-01
Normal-vs-Stage2
7.893000E-01
Normal-vs-Stage3
4.720600E-03
Normal-vs-Stage4
1.815960E-01
Stage1-vs-Stage2
7.747000E-01
Stage1-vs-Stage3
4.623800E-03
Stage1-vs-Stage4
9.503700E-02
Stage2-vs-Stage3
2.09369999999431E-05
Stage2-vs-Stage4
1.618420E-01
Stage3-vs-Stage4
1.396580E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.217400E-01
Normal-vs-AfricanAmerican
8.605000E-01
Normal-vs-Asian
8.957600E-01
Caucasian-vs-AfricanAmerican
2.863000E-01
Caucasian-vs-Asian
5.753400E-01
AfricanAmerican-vs-Asian
7.044000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.311800E-01
Normal-vs-Female
7.089200E-01
Male-vs-Female
9.655200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.936000E-01
Normal-vs-Age(41-60Yrs)
8.416800E-01
Normal-vs-Age(61-80Yrs)
5.388800E-01
Normal-vs-Age(81-100Yrs)
1.181970E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.384600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.422600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.221230E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.239200E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.019800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.733400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.738400E-01
Normal-vs-Daily Drinker
5.979800E-01
Normal-vs-Weekly Drinker
8.653400E-01
Normal-vs-Occasional Drinker
8.282400E-01
Normal-vs-Social Drinker
8.856200E-01
Non Drinker-vs-Daily Drinker
7.547200E-01
Non Drinker-vs-Weekly Drinker
4.107000E-01
Non Drinker-vs-Occasional Drinker
3.113600E-01
Non Drinker-vs-Social Drinker
3.927600E-02
Daily Drinker-vs-Weekly Drinker
5.861600E-01
Daily Drinker-vs-Occasional Drinker
5.527800E-01
Daily Drinker-vs-Social Drinker
2.243800E-01
Weekly Drinker-vs-Occasional Drinker
9.785600E-01
Weekly Drinker-vs-Social Drinker
6.108400E-01
Occasional Drinker-vs-Social Drinker
5.358000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.551790E-01
Normal-vs-Grade 2
2.401900E-02
Normal-vs-Grade 3
1.879610E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.481900E-02
Grade 1-vs-Grade 3
1.189800E-01
Grade 1-vs-Grade 4
1.551790E-01
Grade 2-vs-Grade 3
9.411800E-01
Grade 2-vs-Grade 4
2.401900E-02
Grade 3-vs-Grade 4
1.879610E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.716800E-01
Normal-vs-NonDiabetic
5.995000E-01
Diabetic-vs-NonDiabetic
8.600600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.368000E-01
Normal-vs-NoPancreatitis
6.454200E-01
Pancreatitis-vs-NoPancreatitis
5.597400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.151600E-01
Normal-vs-N1
7.444400E-01
N0-vs-N1
4.458000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.722200E-01
Normal-vs-TP53-NonMutant
7.418200E-01
TP53-Mutant-vs-TP53-NonMutant
8.673200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
